This inventor holds 1 USPTO granted patent. Top assignee: Asahi Kasei Pharma Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Genichi Kusakawa
Introduction
Genichi Kusakawa, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals. With a focus on developing effective remedies for patients undergoing cancer treatment, his work is recognized for addressing vital health concerns.
Latest Patents
Kusakawa holds a notable patent for a medicament designed to mitigate conditions and suppress the onset of peripheral neuropathy induced by anti-malignant tumor agents. His invention specifically targets the side effects caused by oxaliplatin, a common chemotherapy drug. The patent details a unique formulation containing thrombomodulin, administered intravenously to enhance patient comfort and treatment efficacy during cancer therapies.
Career Highlights
Currently working at Asahi Kasei Pharma Corporation, Kusakawa is dedicated to advancing medical treatments through his innovative approaches. His career reflects a strong commitment to improving cancer care and addressing the side effects associated with treatments, showcasing his role as a vital figure in pharmaceutical research.
Collaborations
During his tenure at Asahi Kasei Pharma Corporation, Kusakawa has collaborated with esteemed colleagues, including Takumi Sakai and Yugo Uchida. Their collective expertise fosters an environment of innovation, pushing the boundaries of medical science to deliver enhanced therapeutic solutions for patients.
Conclusion
Genichi Kusakawa's work is a testament to the power of innovation in addressing pressing medical challenges. His patented medicament not only offers hope for cancer patients facing peripheral neuropathy but also underscores the importance of collaboration in driving advancements in healthcare. As he continues his mission at Asahi Kasei Pharma Corporation, Kusakawa remains a pivotal player in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
